查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2024871

退伍軍人菌檢測市場報告：按應用、最終用戶和地區分類（2026-2034 年）

Legionella Testing Market Report by Application (Water Testing, IVD Testing), End User (Diagnostic Laboratories, Hospital and Clinics, and Others), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

2025年全球退伍軍人菌檢測市場規模達3.909億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到6.944億美元，2026年至2034年的複合年成長率（CAGR）為6.40%。糖尿病、腎臟病、人類免疫力缺乏病毒（HIV）、癌症和其他慢性疾病患者人數的增加，導致住院風險上升，這是推動市場成長的主要因素。

退伍軍人菌檢測市場趨勢：

退伍軍人菌病發生率上升

退伍軍人菌症是一種類似肺炎的疾病，其病例數量正在增加。此病通常由細菌引起，症狀嚴重程度不一，從輕微到嚴重不等，有時甚至會導致致命性肺炎，這推動了市場成長。例如，2023年9月，波蘭共報告了166例退伍軍人菌病病例（其中23例死亡）。此外，2023年5月，立陶宛國家公共衛生中心報告稱，正在對立陶宛考納斯地區異常大量的退伍軍人菌病病例進行調查。調查中，在退伍軍人菌提振了 退伍軍人症桿菌檢測市場的前景。退伍軍人菌菌常見於人工和天然水環境中，例如退伍軍人菌治療設備、噴泉、噴霧系統、冷卻塔、水療池以及飯店、住宅和工廠的供水系統。例如，2022年7月，賓州衛生部收到一份報告，兩名患者在接受同一捐贈者肺移植後，經檢查室確診患有退伍軍人菌病。該捐贈者死於河中淡水溺亡，由於退伍軍人菌天然存在於淡水中，因此懷疑感染可能源自於捐贈者。為此，世界各地的衛生部門制定了有效的飲用水安全計畫（WSP），以控制水中退伍軍人菌的滋生。與此疾病相關的常見規章制度包括《地表水處理條例》（SWTR）和《安全飲用水法》（SDWA）。

各種技術進步

針對社區型肺炎患者診斷和治療策略的臨床試驗數量不斷增加，推動了市場發展。醫療產業的領導者正致力於推出新的分子診斷和快速檢測方法，以提供更準確、更快速的檢測結果，並提高退伍軍人菌檢測和控制策略的效率。例如，2023年12月，多元化生物技術公司CCM Biosciences（CCM Bio）推出了CCM 5Prime Sciences（5Prime）業務部門，專注於全球商業化且擁有多項專利的下一代DNA定序和分子診斷組合物。此外，高靈敏度、快速的基於PCR的方法作為檢測退伍軍人菌生長緩慢細菌的傳統培養方法的替代方案，正受到廣泛關注。這些方法使用特異性螢光探針來檢測水樣本中的細菌。包括Biopremier在內的領先品牌提供簡單、可靠、快速的檢測方法，例如用於檢測退伍軍人菌的即時PCR檢測試劑盒。此外，人工智慧（AI）等技術的廣泛應用，例如利用流速和水溫等數據趨勢分析來識別和預測潛在的退伍軍人菌集體爆發，正在推動退伍軍人菌檢測市場佔有率的成長。例如，2024年5月，杜拜中央實驗室引進了新的人工智慧（AI）技術，用於無縫檢測退伍軍人菌——一種可引起急性呼吸道感染疾病的細菌。

加強監管標準

世界各地的監管機構和政府部門正在實施更嚴格的飲用水標準和法規，以遏制退伍軍人菌疫情的爆發，尤其是在旅館、醫療機構和公共場所。這些法規要求定期進行風險評估和水質檢測，以確保公眾安全，從而導致對退伍軍人菌檢測服務的需求增加。例如，2024年4月，美國環保署（EPA）發布了首個“國家飲用水主要法規”，該法規針對某些全氟烷基物質（PFAS）和多氟烷基物質（PFAS），也稱為“永久性化學物質”。此外，世界衛生組織（WHO）建議，人類飲用的水中不應含有退伍軍人菌。許多指南（通常由地方政府和行業標準制定）規定了可接受的水平和檢測程序。這些指南通常包括採取措施和監測細菌數量，以將退伍軍人菌水平保持在特定閾值以下，從而降低相關的健康風險。例如，在美國，疾病管制與預防中心（CDC）針對多個供水系統中的退伍軍人菌檢測和管理提供了指南。此外，其他組織，例如美國暖氣、冷氣與空調工程師協會 (ASHRAE)，也發布了與此感染疾病相關的行為基準值的建議。因此，設施管理人員正在採取糾正措施，以保護使用者的健康。一些提供創新解決方案的領先公司，包括 IWC Innovations，在降低退伍軍人菌風險方面擁有豐富的專業知識，專注於調查、檢測、預防和應對。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球退伍軍人菌檢測市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依應用領域分類

  • 水質檢測
    • 市場區隔：按類型
      • 微生物培養
      • DFA染色
      • PCR
      • 其他
  • 體外診斷檢測
    • 市場區隔：按類型
      • 血液培養
      • 尿抗原檢測
      • DFA染色
      • PCR
      • 其他

第7章 市場區隔：依最終用戶分類

  • 診斷檢查室
  • 醫院和診所
  • 其他

第8章 市場區隔：依地區分類

  • 歐洲
    • 義大利
    • 德國
    • 法國
    • 西班牙
    • 英國
    • 俄羅斯
    • 其他
  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 澳洲
    • 韓國
    • 印尼
    • 新加坡
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章 SWOT 分析

第10章：價值鏈分析

第11章：波特五力分析

第12章：價格分析

第13章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Bio-Rad Laboratories, Inc.
    • Eiken Chemical Co., Ltd.
    • IDEXX
    • Pro-Lab Diagnostics
    • Qiagen NV
    • QuidelOrtho Corporation
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A4020

The global legionella testing market size reached USD 390.9 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 694.4 Million by 2034, exhibiting a growth rate (CAGR) of 6.40% during 2026-2034. The increasing number of individuals who have diabetes, kidney disease, human immunodeficiency virus (HIV), cancer, or other chronic illnesses, are at risk of hospitalization, which is stimulating the market growth.

LEGIONELLA TESTING MARKET ANALYSIS:

  • Major Market Drivers: The increasing demand for legionella testing in workplace buildings is one of the primary drivers bolstering the market. Besides this, the launch of favorable policies by health agencies to develop an effective water safety plan (WSP) is also acting as another significant growth-inducing factor.
  • Key Market Trends: Recent clinical trials on treatment and diagnostic strategies for adult patients with community-acquired pneumonia are positively influencing the market. Moreover, extensive investments in R&D activities are further stimulating the market growth.
  • Competitive Landscape: Some of the prominent players in the global market include Abbott Laboratories, Bio-Rad Laboratories, Inc., Eiken Chemical Co., Ltd., IDEXX, Pro-Lab Diagnostics, Qiagen N.V, QuidelOrtho Corporation, and Thermo Fisher Scientific Inc., among many others.
  • Geographical Trends: Europe exhibits a clear dominance in the market. This can be attributed to the growing number of public health campaigns and educational programs, which is escalating the demand for legionella testing services. Moreover, the increasing focus among key players on maintaining high standards of patient care and safety is bolstering the regional market.
  • Challenges and Opportunities: The complexities and high cost of legionella testing procedures are among the primary factors hindering the market growth. However, the introduction of simpler and more cost-effective testing kits that can help in making legionella testing more accessible is expected to fuel the market over the forecasted period.

LEGIONELLA TESTING MARKET TRENDS:

Rising Prevalence of Legionellosis

The rising incidences related to Legionellosis disease, which is a pneumonia-like illness, usually caused by a bacterium that varies in severity from mild to severe illness and sometimes fatal form of pneumonia, are propelling the market. For example, in September 2023, a total of 166 cases of legionellosis, including 23 deaths, were reported from Poland. Additionally, in May 2023, the Lithuanian National Public Health Center reported the investigation of an unexpected number of cases of Legionnaires' disease in the Kaunas district of Lithuania, Europe. In line with this, Legionella bacteria was found in water samples from the buildings where the cases resided. Furthermore, the proliferation of Legionella-causing bacteria that are commonly found in several artificial and natural aquatic environments, such as respiratory therapy equipment, fountains, misting devices, cooling towers, spa pools, and water systems in hotels, homes, factories, etc., is also catalyzing the legionella testing market outlook. For instance, in July 2022, the Pennsylvania Department of Health received two reports of laboratory-confirmed Legionnaires disease in patients who received lung transplants from the same donor at a single Pennsylvania hospital. The donor's cause of death was freshwater drowning in a river, raising suspicion of potential donor-derived transmission because Legionella bacteria naturally live in fresh water. As a result, health agencies in various countries are launching an effective water safety plan (WSP) to reduce the proliferation of Legionella in the water. Some of the common rules and regulations pertinent to the disease include the Surface Water Treatment Rule (SWTR) and the Safe Drinking Water Act (SDWA).

Various Technological Advancements

The increasing number of clinical trials on diagnostic and treatment strategies for patients with community-acquired pneumonia is strengthening the market. Key players in the healthcare industry are focusing on introducing novel molecular diagnostics and rapid test methods, as they offer more accurate and quicker testing outcomes, thereby improving the efficiency of legionella testing and control strategies. For example, in December 2023, one of the diversified biotechnology companies, CCM Biosciences (CCM Bio), launched its business unit, CCM 5Prime Sciences (5Prime), focused on the globally commercialized and multiple patent-protected compositions for next-generation DNA sequencing and molecular diagnostics. Apart from this, sensitive and rapid PCR-based methods are gaining immense traction as alternatives to the conventional culture system for the detection of slow-growing bacteria, such as Legionella spp. They use specific fluorescent probes that allow them to detect bacteria in water samples. Prominent brands, including Biopremier, offer simple, reliable, and rapid procedures, including real-time PCR detection test kits, to detect Legionella spp. Moreover, the widespread integration of technologies, such as artificial intelligence (AI), to identify and predict potential legionella outbreaks by analyzing data trends, including flow rates and water temperature, is elevating the legionella testing market share. For example, in May 2024, the Dubai Central Laboratory introduced a new artificial intelligence (AI) technology to seamlessly detect Legionella, a bacterium that causes acute respiratory infections.

Growing Regulatory Standards

Regulatory and government bodies across the globe are implementing stricter drinking water standards and regulations to control legionella outbreaks, especially in hotels, healthcare facilities, public buildings, etc. These regulations mandate regular risk and water testing assessments to ensure public safety, thereby escalating the demand for legionella testing services. For example, in April 2024, the U.S. Environmental Protection Agency (EPA) released the first-ever National Primary Drinking Water Regulation for certain per- and polyfluoroalkyl substances (PFAS), also known as 'forever chemicals.' Besides this, for drinking water, the World Health Organization (WHO) suggests that Legionella bacteria should be absent in water utilized for human consumption. Numerous guidelines, often set by local authorities or industry standards, indicate acceptable levels and testing protocols. They generally involve implementing measures and monitoring Legionella counts to ensure they remain below certain thresholds to reduce associated health risks. For instance, in the United States, the Centers for Disease Control and Prevention (CDC) provides guidance on Legionella testing and management for several water systems. Furthermore, other organizations, such as the American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE), provide recommendations for action levels related to this infection. Consequently, facility managers are taking corrective actions to protect the health of occupants. Some of the leaders in providing innovative solutions, including IWC Innovations, offer expertise in Legionella risk mitigation, focusing on investigation, detection, prevention, and remediation of the disease.

LEGIONELLA TESTING MARKET SEGMENTATION:

Breakup by Application:

  • Water Testing
    • Microbial Culture
    • DFA Stain
    • PCR
    • Others
  • IVD Testing
    • Blood Culture
    • Urine Antigen Test
    • DFA Stain
    • PCR
    • Others

Currently, water testing holds the majority of the market share

The increasing need for comprehensive and regular water quality assessments in several facilities, including hotels, commercial buildings, hospitals, residential complexes, etc., where stagnant water can become a breeding ground for legionella bacteria is driving the growth in this segmentation. Moreover, the widespread adoption of water testing methods that can allow for timely intervention measures is also acting as another significant growth-inducing factor. For example, in May 2022, ChemREADY, one of the manufacturers of water and wastewater treatment chemicals, introduced its Legionella testing services and product line to mitigate water-borne infection in building water systems. Besides this, the growing number of educational and training programs for building owners, employees, facility managers, etc., is creating lucrative opportunities for water consulting and testing services. For instance, in June 2023, Consulting and Testing Services, Inc. (CTSI), one of the prominent providers of industrial hygiene, offered infection control and environmental testing services in New Jersey to identify sources of Legionella bacteria to support water management programs.

Breakup by End User:

  • Diagnostic Laboratories
  • Hospital and Clinics

Among these, diagnostic laboratories currently account for the largest market share

The increasing requirement for timely and accurate results that are crucial for timely interventions is augmenting the market across this segment. For instance, diagnostic labs, including LabCorp and Quest Diagnostics, offer comprehensive legionella testing services, ranging from collecting water samples from various types of facilities to analyzing them using novel methods, such as polymerase chain reaction (PCR), culture techniques, serology, etc. Additionally, continuous collaborations and partnerships are expected to fuel the segment's growth in the coming years. For instance, in December 2021, Pace Analytical Services, one of the companies that offer environmental sampling and analytical support services to detect trace-level inorganic and organic contaminants in water, soil, air, etc., acquired Special Pathogens Laboratory to strengthen testing capabilities for Legionella disease.

Breakup by Region:

  • Europe
    • Italy
    • Germany
    • France
    • Spain
    • United Kingdom
    • Russia
    • Others
  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Singapore
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

According to the legionella testing industry analysis, Europe exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include Europe (Italy, Germany, France, Spain, the United Kingdom, Russia, and others); North America (the United States and Canada); Asia Pacific (China, Japan, Australia, South Korea, Indonesia, Singapore, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Europe accounted for the largest market share.

The rising prevalence of infections, such as Legionella, which can lead to severe pneumonia, is bolstering the market across Europe. For example, as per the data published by the National Center for Biotechnology Information (NCBI) in October 2023, the European Centre for Disease Prevention and Control (ECDC) reported a rise in Legionella outbreaks and confirmed cases across its member states. Similarly, in 2022, around 194 deaths were confirmed from Legionnaires' disease in France. Apart from this, the implementation of stringent regulations by government bodies that mandate regular and comprehensive water testing in public buildings and facilities that are at high risk of legionella contamination is also acting as another significant growth-inducing factor. For instance, guidelines are outlined by the German Technical and Scientific Association for Gas and Water (DVGW) that require all healthcare facilities to conduct legionella testing at least bi-annually. Additionally, the rising adoption of advanced testing technologies, such as quantitative polymerase chain reaction (qPCR) methods, is expected to bolster the regional market. For example, various companies like, Eurofins Scientific and SGS SA, are providing cutting-edge testing services that meet the escalating demand for accuracy and efficiency in legionella detection across Europe.

COMPETITIVE LANDSCAPE:

The legionella testing market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Eiken Chemical Co., Ltd.
  • IDEXX
  • Pro-Lab Diagnostics
  • Qiagen N.V
  • QuidelOrtho Corporation
  • Thermo Fisher Scientific Inc.

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Legionella Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Application

  • 6.1 Water Testing
    • 6.1.1 Market Trends
    • 6.1.2 Market Breakup by Type
      • 6.1.2.1 Microbial Culture
      • 6.1.2.2 DFA Stain
      • 6.1.2.3 PCR
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 IVD Testing
    • 6.2.1 Market Trends
    • 6.2.2 Market Breakup by Type
      • 6.2.2.1 Blood Culture
      • 6.2.2.2 Urine Antigen Test
      • 6.2.2.3 DFA Stain
      • 6.2.2.4 PCR
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by End User

  • 7.1 Diagnostic Laboratories
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Hospital and Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 Europe
    • 8.1.1 Italy
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Germany
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
    • 8.1.3 France
      • 8.1.3.1 Market Trends
      • 8.1.3.2 Market Forecast
    • 8.1.4 Spain
      • 8.1.4.1 Market Trends
      • 8.1.4.2 Market Forecast
    • 8.1.5 United Kingdom
      • 8.1.5.1 Market Trends
      • 8.1.5.2 Market Forecast
    • 8.1.6 Russia
      • 8.1.6.1 Market Trends
      • 8.1.6.2 Market Forecast
    • 8.1.7 Others
      • 8.1.7.1 Market Trends
      • 8.1.7.2 Market Forecast
  • 8.2 North America
    • 8.2.1 United States
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Canada
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 China
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 Japan
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 Australia
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 South Korea
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Indonesia
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Singapore
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weakness
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porter's Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Bio-Rad Laboratories, Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Eiken Chemical Co., Ltd.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
    • 13.3.4 IDEXX
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Pro-Lab Diagnostics
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Qiagen N.V
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 QuidelOrtho Corporation
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 inancials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Thermo Fisher Scientific Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Legionella Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Legionella Testing Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: Legionella Testing Market: Breakup by Application (in %), 2025
  • Figure 5: Global: Legionella Testing (Water Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 6: Global: Legionella Testing Market for Water Testing: Breakup by Type (in %), 2025
  • Figure 7: Global: Legionella Testing (Water Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 8: Global: Legionella Testing (IVD Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Legionella Testing Market for IVD Testing: Breakup by Type (in %), 2025
  • Figure 10: Global: Legionella Testing (IVD Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Legionella Testing Market: Breakup by End User (in %), 2025
  • Figure 12: Global: Legionella Testing (Diagnostic Laboratory) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Legionella Testing (Diagnostic Laboratory) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Legionella Testing (Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Legionella Testing (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Legionella Testing (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Legionella Testing (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Legionella Testing Market: Breakup by Region (in %), 2025
  • Figure 19: Europe: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Europe: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Europe: Legionella Testing Market: Breakup by Country (in %), 2025
  • Figure 22: Italy: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Italy: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Germany: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Germany: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: France: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: France: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Spain: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Spain: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: United Kingdom: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: United Kingdom: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Russia: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Russia: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Others: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Others: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: North America: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: North America: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: North America: Legionella Testing Market: Breakup by Country (in %), 2025
  • Figure 39: United States: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: United States: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Canada: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Canada: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Asia Pacific: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Asia Pacific: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Asia Pacific: Legionella Testing Market: Breakup by Country (in %), 2025
  • Figure 46: China: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: China: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Japan: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Japan: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Australia: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Australia: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: South Korea: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: South Korea: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Indonesia: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Indonesia: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Singapore: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Singapore: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Others: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Others: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Latin America: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Latin America: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Latin America: Legionella Testing Market: Breakup by Country (in %), 2025
  • Figure 63: Brazil: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Brazil: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Mexico: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Mexico: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Others: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Others: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Middle East and Africa: Legionella Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Middle East and Africa: Legionella Testing Market: Breakup by Country (in %), 2025
  • Figure 71: Middle East and Africa: Legionella Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Global: Legionella Testing Industry: SWOT Analysis
  • Figure 73: Global: Legionella Testing Industry: Value Chain Analysis
  • Figure 74: Global: Legionella Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Legionella Testing Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Legionella Testing Market: Breakup by Application (in Million USD), 2020 & 2025
  • Table 3: Global: Legionella Testing Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Legionella Testing Market: Breakup by End User (in Million USD), 2020 & 2025
  • Table 5: Global: Legionella Testing Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 6: Global: Legionella Testing Market: Breakup by Region (in Million USD), 2020 & 2025
  • Table 7: Global: Legionella Testing Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 8: Global: Legionella Testing Industry: Key Price Indicator
  • Table 9: Global: Legionella Testing Market: Competitive Structure
  • Table 10: Global: Legionella Testing Market: Key Players